Stratos Wealth Partners LTD. trimmed its position in shares of Cigna Group (NYSE:CI - Free Report) by 15.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,072 shares of the health services provider's stock after selling 949 shares during the quarter. Stratos Wealth Partners LTD.'s holdings in Cigna Group were worth $1,669,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC raised its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after acquiring an additional 318 shares in the last quarter. Proficio Capital Partners LLC grew its stake in shares of Cigna Group by 24.5% in the 4th quarter. Proficio Capital Partners LLC now owns 864 shares of the health services provider's stock valued at $239,000 after purchasing an additional 170 shares during the last quarter. Independent Advisor Alliance grew its stake in shares of Cigna Group by 179.3% in the 4th quarter. Independent Advisor Alliance now owns 5,895 shares of the health services provider's stock valued at $1,628,000 after purchasing an additional 3,784 shares during the last quarter. PFG Advisors grew its stake in shares of Cigna Group by 16.2% in the 4th quarter. PFG Advisors now owns 2,615 shares of the health services provider's stock valued at $722,000 after purchasing an additional 364 shares during the last quarter. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of Cigna Group by 27.6% in the fourth quarter. Sequoia Financial Advisors LLC now owns 6,316 shares of the health services provider's stock valued at $1,744,000 after buying an additional 1,368 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
Cigna Group Trading Down 2.0%
Shares of NYSE CI traded down $6.07 during midday trading on Friday, hitting $302.71. The stock had a trading volume of 1,590,753 shares, compared to its average volume of 1,741,564. The company has a market capitalization of $80.86 billion, a price-to-earnings ratio of 16.76, a PEG ratio of 0.90 and a beta of 0.44. Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.65. The company has a fifty day moving average price of $317.02 and a 200 day moving average price of $310.62.
Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating the consensus estimate of $6.35 by $0.39. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The company's revenue was up 14.4% compared to the same quarter last year. During the same period in the previous year, the company posted $6.47 EPS. On average, analysts predict that Cigna Group will post 29.77 earnings per share for the current year.
Cigna Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd were issued a dividend of $1.51 per share. The ex-dividend date was Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 2.00%. Cigna Group's payout ratio is currently 33.44%.
Analyst Ratings Changes
A number of brokerages recently weighed in on CI. Wall Street Zen raised Cigna Group from a "buy" rating to a "strong-buy" rating in a report on Tuesday, April 8th. Robert W. Baird decreased their target price on Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Barclays reiterated an "overweight" rating and set a $385.00 target price (up from $382.00) on shares of Cigna Group in a research report on Monday, June 2nd. Truist Financial boosted their target price on Cigna Group from $385.00 to $405.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Finally, Piper Sandler boosted their target price on Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Two analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, Cigna Group has a consensus rating of "Buy" and a consensus target price of $380.39.
Check Out Our Latest Research Report on CI
Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also

Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.